focus -WSS

focus

author：fashion 2025-09-30 22:04:20 - browse：9291

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： An innovative path out of biotech’s “valley of death”

explore

Wikipedia

WSS

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

A Greenpeace activist is fined for crash

Companies helping big Covid

White House drug shortages task force keeps mum with Congress

Large hospital system sues Multiplan for low

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

hotspot

focus

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Women's World Cup brings attention to abuse in soccer

Moonlake's readout produced a cash windfall. Risks remain

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Sports medicine is finally prioritizing gender equality

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Malaria cases in Florida and Texas: Here’s what you need to know

Novo acquires Inversago for up to $1 billion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grail's uphill battle for Medicare to cover its cancer screening test

knowledge

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

EU fines Illumina $475 million over Grail acquisition

Vermont grapples with historic flooding as more rainstorms head for Northeast

The history of OxyContin, told through Purdue Pharma documents

Listen: Your guide to Wegovy's blockbuster heart study

An innovative path out of biotech’s “valley of death”

explore

focus

Wikipedia

explore